234 related articles for article (PubMed ID: 10026227)
1. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells.
Rao GN; Katki KA; Madamanchi NR; Wu Y; Birrer MJ
J Biol Chem; 1999 Feb; 274(9):6003-10. PubMed ID: 10026227
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression.
Rao GN; Runge MS
J Biol Chem; 1996 Aug; 271(34):20805-10. PubMed ID: 8702835
[TBL] [Abstract][Full Text] [Related]
3. ATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cells.
Ghosh SK; Gadiparthi L; Zeng ZZ; Bhanoori M; Tellez C; Bar-Eli M; Rao GN
J Biol Chem; 2002 Jun; 277(24):21325-31. PubMed ID: 11925444
[TBL] [Abstract][Full Text] [Related]
4. Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1).
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Suzaki Y; Abe S; Hasegawa T; Tamaki T
Biochem Pharmacol; 2002 Nov; 64(10):1521-31. PubMed ID: 12417265
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells.
Yamakawa T; Tanaka S; Yamakawa Y; Kamei J; Numaguchi K; Motley ED; Inagami T; Eguchi S
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):752-8. PubMed ID: 12006386
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression.
Rao GN
Cell Signal; 1997 Feb; 9(2):181-7. PubMed ID: 9113418
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
8. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
9. C3 toxin activates the stress signaling pathways, JNK and p38, but antagonizes the activation of AP-1 in rat-1 cells.
Beltman J; Erickson JR; Martin GA; Lyons JF; Cook SJ
J Biol Chem; 1999 Feb; 274(6):3772-80. PubMed ID: 9920930
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells.
Yamakawa T; Eguchi S; Yamakawa Y; Motley ED; Numaguchi K; Utsunomiya H; Inagami T
Hypertension; 1998 Jan; 31(1 Pt 2):248-53. PubMed ID: 9453311
[TBL] [Abstract][Full Text] [Related]
11. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells.
Balmanno K; Cook SJ
Oncogene; 1999 May; 18(20):3085-97. PubMed ID: 10340380
[TBL] [Abstract][Full Text] [Related]
12. Activation of mu-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade.
Shoda T; Fukuda K; Uga H; Mima H; Morikawa H
Anesthesiology; 2001 Oct; 95(4):983-9. PubMed ID: 11605942
[TBL] [Abstract][Full Text] [Related]
13. Activation of c-Jun N-terminal kinase 1 by UV irradiation is inhibited by wortmannin without affecting c-iun expression.
Fritz G; Kaina B
Mol Cell Biol; 1999 Mar; 19(3):1768-74. PubMed ID: 10022864
[TBL] [Abstract][Full Text] [Related]
14. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
15. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
17. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells.
Bhunia AK; Han H; Snowden A; Chatterjee S
J Biol Chem; 1997 Jun; 272(25):15642-9. PubMed ID: 9188453
[TBL] [Abstract][Full Text] [Related]
18. Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase.
Chen Q; Li W; Quan Z; Sumpio BE
J Vasc Surg; 2003 Mar; 37(3):660-8. PubMed ID: 12618707
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin stimulates the ERK-->Elk-1-->Fos/AP-1 pathway in mesangial cells.
El-Dahr SS; Dipp S; Baricos WH
Am J Physiol; 1998 Sep; 275(3):F343-52. PubMed ID: 9729506
[TBL] [Abstract][Full Text] [Related]
20. Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21(waf1/cip1).
Bhanoori M; Yellaturu CR; Ghosh SK; Hassid A; Jennings LK; Rao GN
Oncogene; 2003 Jan; 22(1):117-30. PubMed ID: 12527914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
